To preferentially increase lumbar SNA [15,16,17,18]. Studies using animal models of pre-diabetes and the metabolic syndrome have reported augmented a-adrenergic vascular responsiveness to adrenergic agonists in isolated vascular preparations [19,20]. As noted above, NPY-mediated vascular moduPre-Diabetes and Sympathetic Vascular Controllation becomes more pronounced under conditions of elevated SNA [6,7,8]; however, to date, studies addressing NPY/Y1Rmediated vascular control in pre-diabetes are lacking. Furthermore, there have been no studies investigating NPY and aadrenergic co-modulation of vascular control in pre-diabetes. The overall aim of the present study was to investigate if prediabetes modifies sympathetic Y1R and a1R control of basal skeletal muscle blood flow (Qfem) and vascular conductance (VC). Thus, we tested the independent and dependent (synergistic) functional contributions of endogenous Y1R and a1R activation on Qfem and VC in vivo and MedChemExpress BIBS39 hypothesized that pre-diabetes augments Y1R and a1R vascular modulation. Concurrently, we hypothesized that skeletal muscle NPY concentration and Y1R and a1R expression would be upregulated in pre-diabetic rats.Materials and MethodsAll animal procedures were approved by the Council on Animal Care at The University of Western Ontario (protocol number: 2008-066). All invasive procedures were performed under achloralose and urethane anesthetic, and all efforts were made to minimize animal suffering.right iliac artery, isolating it from the right iliac vein and its surrounding fat. The right iliac artery was cannulated (PE-50 tubing) and the cannula was advanced to the bifurcation of the descending aorta. This cannula was used for localized drug delivery to the left hindlimb. Following cannulation, gauze was 18055761 removed and care was taken to reposition the gut. Incisions were closed with sterile wound clips (9 mm stainless steel wound clips). A blood MedChemExpress 14636-12-5 sample was then taken from the carotid cannula in order to evaluate blood glucose levels, lactate levels, and pH using an iSTAT portable clinical analyzer (Abbott Laboratories, Abbott Park, IL, USA). Using microscopic assistance, the left femoral artery was carefully isolated from surrounding nerves and vessels. Qfem was measured beat-by-beat using a Transonic flow probe (0.7 PSB) and flowmeter (model TS420 Perivascular Flowmeter Module; Transonic Systems, Ithica, NY, USA). The flow probe was placed around the 
left femoral artery ,3 mm from the femoral triangle and innocuous water-soluble ultrasound gel was applied over the opened area of the left hindlimb to keep tissue hydrated and to maintain adequate flow signal.Experimental protocolOnce surgery was completed, animals recovered for 1 hour. Prior to drug treatments, vehicle (160 ml of 0.9 saline) was delivered, followed by a 15-minute recovery period. Baseline data were recorded for 5 minutes followed by five separate drug infusions [5,25,26,27]. Using a repeated measures design, drug infusions were delivered at a rate of 16 ml/sec in the following order: 1) 250 ml of 0.2 mg/kg acetylcholine chloride (ACh, SigmaAldrich, St. Louis, MO, USA), 2) 160 ml of 100 mg/kg BIBP3226, a specific Y1R antagonist (TOCRIS, Ellisville, MO, USA), 3) 160 ml of 20 mg/kg prazosin, a specific a1R antagonist (SigmaAldrich, St. Louis, MO, USA), 4) combined 100 mg/kg BIBP3226+20 mg/kg prazosin, and 5) 160 ml of 5 mg/kg sodium nitroprusside (SNP, i.v., sodium nitroprussiate dihydrate, SigmaAldrich, St. Louis, MO, USA).To preferentially increase lumbar SNA [15,16,17,18]. Studies using animal models of pre-diabetes and the metabolic syndrome have reported augmented a-adrenergic vascular responsiveness to adrenergic agonists in isolated vascular preparations [19,20]. As noted above, NPY-mediated vascular moduPre-Diabetes and Sympathetic Vascular Controllation becomes more pronounced under conditions of elevated SNA [6,7,8]; however, to date, studies addressing NPY/Y1Rmediated vascular control in pre-diabetes are lacking. Furthermore, there have been no studies investigating NPY and aadrenergic co-modulation of vascular control in pre-diabetes. The overall aim of the present study was to investigate if prediabetes modifies sympathetic Y1R and a1R control of basal skeletal muscle blood flow (Qfem) and vascular conductance (VC). Thus, we tested the independent and dependent (synergistic) functional contributions of endogenous Y1R and a1R activation on Qfem and VC in vivo and hypothesized that pre-diabetes augments Y1R and a1R vascular modulation. Concurrently, we hypothesized that skeletal muscle NPY concentration and Y1R and a1R expression would be upregulated in pre-diabetic rats.Materials and MethodsAll animal procedures were approved by the Council on Animal Care at The University of Western Ontario (protocol number: 2008-066). All invasive procedures were performed under achloralose and urethane anesthetic, and all efforts were made to minimize animal suffering.right iliac artery, isolating it from the right iliac vein and its surrounding fat. The right iliac artery was cannulated (PE-50 tubing) and the cannula was advanced to the bifurcation of the descending aorta. This cannula was used for localized drug delivery to the left hindlimb. Following cannulation, gauze was 18055761 removed and care was taken to reposition the gut. Incisions were closed with sterile wound clips (9 mm stainless steel wound clips). A blood sample was then taken from the carotid cannula in order to evaluate blood glucose levels, lactate levels, and pH using an iSTAT portable clinical analyzer (Abbott Laboratories, Abbott Park, IL, USA). Using microscopic assistance, the left femoral artery was carefully isolated from surrounding nerves and vessels. Qfem was measured beat-by-beat using a Transonic flow probe (0.7 PSB) and flowmeter (model TS420 Perivascular Flowmeter Module; Transonic Systems, Ithica, NY, USA). The flow probe was placed around the left femoral artery ,3 mm from the femoral triangle and innocuous water-soluble ultrasound gel was applied over the opened area of the left hindlimb to keep tissue hydrated and to maintain adequate flow signal.Experimental protocolOnce surgery was completed, animals recovered for 1 hour. Prior to drug treatments, vehicle (160 ml of 0.9 saline) was delivered, followed by a 15-minute recovery period. Baseline data were recorded for 5 minutes followed by five separate drug infusions [5,25,26,27]. Using a repeated measures design, drug infusions were delivered at a rate of 16 ml/sec in the following order: 1) 250 ml of 0.2 mg/kg acetylcholine chloride (ACh, SigmaAldrich, St. Louis, MO, USA), 2) 160 ml of 100 mg/kg BIBP3226, a specific Y1R antagonist (TOCRIS, Ellisville, MO, USA), 3) 160 ml of 20 mg/kg prazosin, a specific a1R antagonist (SigmaAldrich, St. Louis, MO, USA), 4) combined 100 mg/kg BIBP3226+20 mg/kg prazosin, and 5) 160 ml of 5 mg/kg sodium nitroprusside (SNP, i.v., 
sodium nitroprussiate dihydrate, SigmaAldrich, St. Louis, MO, USA).